Home › Companies › Strata Critical Medical, Inc. › 2025-2026
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and Strata Critical Medical, Inc.’s Form 8-K, filed June 3, 2026 (Item 5.07 on EDGAR). Page generated November 20, 2026.
Meeting of May 28, 2026: 4 items on Strata Critical Medical, Inc.’s Form 8-K, filed June 3, 2026: 2 approved · 2 passed (calculated).
Notable dissent: 1 director (15.1% against).
Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided
Proxy season: 2024-2025 2025-2026
Activist investors: Third Point (13D, 5.8%, as of October 15, 2026) · Becker Drapkin (13F, 5.0%, as of September 30, 2026)
Explore Strata Critical Medical, Inc. in the interactive database Compare manager voting policies
These tallies are Strata Critical Medical, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 3, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: William A. Heyburn | 46,050,902 | -- | -- | 505,421 | 12,687,496 | 99% | Passed (calculated) | — |
| Elect Director: Andrew Lauck | 39,525,159 | -- | -- | 7,031,164 | 12,687,496 | 85% | Passed (calculated) | — |
| 2. The appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026 | 58,946,832 | 65,815 | 231,172 | -- | -- | 99.9% | Approved | — |
| 3. On an advisory, non-binding basis, the compensation of the Company's named executive officers (the "Say-on-Pay" vote) | 38,497,962 | 8,022,682 | 35,679 | -- | 12,687,496 | 83% | Approved | — |
Source: Strata Critical Medical, Inc., Form 8-K, filed with the SEC on June 3, 2026 — read the filing on EDGAR.
See voting trends for Health Care companies, 2025-2026: shareholder support by sector and by company size.
137 asset managers disclosed a vote on at least one Strata Critical Medical, Inc. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 6 wordings of this item as funds reported it.
85% Majority: yes · of votes cast
Description as filed by funds: Elect Class II Directors for terms expiring in 2029: Andrew Lauck
Strata Critical Medical, Inc.’s own tally for this item (“Elect Director: Andrew Lauck”): 39,525,159 for, 7,031,164 withheld, per its Form 8-K filed June 3, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 85% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 46 asset managers below reported 14,813,867 for, 3,062,428 withheld, 31,589 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| ARK ETF Trust | 7,369,790 | 0 | 0 | 0 | For |
| Vanguard | 3,008,626 | 0 | 12 | 0 | For |
| Royce | 2,195,581 | 0 | 0 | 0 | For |
| FIRST EAGLE FUNDS | 0 | 0 | 0 | 1,961,041 | Withhold |
| BlackRock | 1,284,118 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 0 | 470,318 | Withhold |
| BNY Mellon | 312,990 | 0 | 0 | 0 | For |
| Charles Schwab | 201,557 | 0 | 0 | 0 | For |
| American Century | 0 | 0 | 0 | 158,748 | Withhold |
| Russell Investments | 143,683 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 0 | 0 | 0 | 125,339 | Withhold |
| TIAA | 0 | 0 | 0 | 106,509 | Withhold |
| JPMorgan | 97,721 | 0 | 0 | 0 | For |
| Equitable | 32,030 | 0 | 0 | 49,530 | Mixed |
| Lincoln Financial | 0 | 0 | 0 | 49,927 | Withhold |
| Fidelity | 37,253 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 0 | 0 | 0 | 33,188 | Withhold |
| Global X | 32,469 | 0 | 0 | 0 | For |
| Pacific Life | 30,233 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 29,691 | 0 | 0 | 0 | For |
| Venerable Variable Insurance Trust | 5,311 | 0 | 0 | 21,189 | Mixed |
| Jackson National | 0 | 0 | 25,349 | 0 | Abstain |
| Virtus | 0 | 0 | 0 | 22,136 | Withhold |
| AQR | 0 | 0 | 0 | 15,781 | Withhold |
| Goldman Sachs | 14,029 | 0 | 0 | 0 | For |
Showing the 25 largest of 46 asset managers. All 46 are in the interactive database (link above).
Combines 6 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
Description as filed by funds: Elect Class II Directors for terms expiring in 2029: William A. Heyburn
Strata Critical Medical, Inc.’s own tally for this item (“Elect Director: William A. Heyburn”): 46,050,902 for, 505,421 withheld, per its Form 8-K filed June 3, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 46 asset managers below reported 17,857,945 for, 49,938 withheld, 1 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| ARK ETF Trust | 7,369,790 | 0 | 0 | 0 | For |
| Vanguard | 3,006,270 | 0 | 1 | 2,367 | For |
| Royce | 2,195,581 | 0 | 0 | 0 | For |
| FIRST EAGLE FUNDS | 1,961,041 | 0 | 0 | 0 | For |
| BlackRock | 1,284,118 | 0 | 0 | 0 | For |
| Dimensional | 470,318 | 0 | 0 | 0 | For |
| BNY Mellon | 312,990 | 0 | 0 | 0 | For |
| Charles Schwab | 201,557 | 0 | 0 | 0 | For |
| American Century | 158,748 | 0 | 0 | 0 | For |
| Russell Investments | 143,683 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 125,339 | 0 | 0 | 0 | For |
| TIAA | 106,509 | 0 | 0 | 0 | For |
| JPMorgan | 97,721 | 0 | 0 | 0 | For |
| Equitable | 81,560 | 0 | 0 | 0 | For |
| Lincoln Financial | 49,927 | 0 | 0 | 0 | For |
| Fidelity | 37,253 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 33,188 | 0 | 0 | 0 | For |
| Global X | 0 | 0 | 0 | 32,469 | Withhold |
| Pacific Life | 30,233 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 29,691 | 0 | 0 | 0 | For |
| Venerable Variable Insurance Trust | 26,500 | 0 | 0 | 0 | For |
| Jackson National | 25,349 | 0 | 0 | 0 | For |
| Virtus | 22,136 | 0 | 0 | 0 | For |
| AQR | 15,781 | 0 | 0 | 0 | For |
| Goldman Sachs | 14,029 | 0 | 0 | 0 | For |
Showing the 25 largest of 46 asset managers. All 46 are in the interactive database (link above).
Combines 5 wordings of this item as funds reported it.
83% Approved · of votes cast
Prior year: 66.8% for (May 6, 2025 meeting) ▲ 16.0 pts
Description as filed by funds: Advisory Vote on the Compensation of our Named Executive Officers.
Strata Critical Medical, Inc.’s own tally for this item (“3. On an advisory, non-binding basis, the compensation of the Company's named executive officers (the "Say-on-Pay" vote)”): 38,497,962 for, 8,022,682 against — passed, per its Form 8-K filed June 3, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The Company's stockholders approved, on an advisory, non-binding basis, the compensation of the Company's named executive officers (the "Say-on-Pay" vote).”
Support: 83% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| ARK ETF Trust | 7,369,790 | 0 | 0 | 0 | For |
| Vanguard | 2,522,129 | 486,509 | 0 | 0 | Mixed |
| Royce | 2,195,581 | 0 | 0 | 0 | For |
| FIRST EAGLE FUNDS | 0 | 1,961,041 | 0 | 0 | Against |
| BlackRock | 1,284,118 | 0 | 0 | 0 | For |
| Dimensional | 0 | 470,318 | 0 | 0 | Against |
| BNY Mellon | 312,990 | 0 | 0 | 0 | For |
| Charles Schwab | 0 | 201,557 | 0 | 0 | Against |
| American Century | 0 | 158,748 | 0 | 0 | Against |
| Russell Investments | 0 | 143,683 | 0 | 0 | Against |
| Principal Exchange-Traded Funds | 0 | 125,339 | 0 | 0 | Against |
| TIAA | 106,509 | 0 | 0 | 0 | For |
| JPMorgan | 0 | 97,721 | 0 | 0 | Against |
| Equitable | 32,030 | 49,530 | 0 | 0 | Mixed |
| RBB FUND, INC. | 62,661 | 0 | 0 | 0 | For |
| Lincoln Financial | 44,600 | 5,327 | 0 | 0 | Mixed |
| Fidelity | 37,253 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 0 | 33,188 | 0 | 0 | Against |
| Global X | 0 | 32,469 | 0 | 0 | Against |
| Pacific Life | 30,233 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 29,691 | 0 | 0 | 0 | For |
| Venerable Variable Insurance Trust | 0 | 26,500 | 0 | 0 | Against |
| Jackson National | 0 | 25,349 | 0 | 0 | Against |
| Virtus | 0 | 22,136 | 0 | 0 | Against |
| AQR | 0 | 15,781 | 0 | 0 | Against |
Fund voting reports, all 46 managers: 14,050,178 for, 3,920,367 against. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Third Point | 5,000,000 | 0 | 0 | 0 | For |
| Northern Right Capital Management, L.P. | 3,069,325 | 0 | 0 | 0 | For |
| First Eagle Investment Management, LLC | 0 | 2,266,243 | 0 | 0 | Against |
| Amova Asset Management Co., Ltd. | 0 | 1,654,361 | 0 | 0 | Against |
| Uniplan Investment Counsel, Inc. | 1,007,897 | 0 | 0 | 0 | For |
| ARK Investment Management LLC | 712,524 | 0 | 0 | 0 | For |
| BlackRock | 624,107 | 21,107 | 0 | 0 | For |
| Newton Investment Management North America, LLC | 611,644 | 0 | 0 | 0 | For |
| Royce | 565,319 | 0 | 0 | 0 | For |
| State Street | 524,867 | 1,491 | 0 | 0 | For |
| Vanguard | 284,378 | 30,312 | 0 | 0 | Mixed |
| Russell Investments | 0 | 266,288 | 0 | 0 | Against |
| Northern Trust | 0 | 255,716 | 0 | 0 | Against |
| Charles Schwab | 0 | 201,808 | 0 | 0 | Against |
| American Century | 0 | 158,748 | 0 | 0 | Against |
| MELLON INVESTMENTS Corp | 144,325 | 0 | 0 | 0 | For |
| PRINCIPAL GLOBAL INVESTORS | 0 | 128,411 | 0 | 0 | Against |
| STATE OF WISCONSIN INVESTMENT BOARD | 0 | 118,359 | 0 | 0 | Against |
| Nuveen | 117,454 | 0 | 0 | 0 | For |
| Goldman Sachs | 116,893 | 0 | 0 | 0 | For |
| Renaissance | 0 | 111,480 | 0 | 0 | Against |
| Dimensional | 0 | 89,209 | 0 | 0 | Against |
| AllianceBernstein | 0 | 73,940 | 0 | 0 | Against |
| STIFEL NICOLAUS & CO INC \MO\ | 0 | 72,768 | 0 | 0 | Against |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC | 0 | 69,875 | 0 | 0 | Against |
Institutional-manager reports, all 109 managers: 12,923,190 for, 6,011,383 against. Showing the 25 largest; every one is in the interactive database (link above).
99.9% Approved · of votes cast
Prior year: 99.9% for (May 6, 2025 meeting) unchanged
Description as filed by funds: RATIFY APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR 2026 (DELOITTE & TOUCHE LLP).
Strata Critical Medical, Inc.’s own tally for this item (“2. The appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026”): 58,946,832 for, 65,815 against — passed, per its Form 8-K filed June 3, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The Company's stockholders ratified the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 46 asset managers below reported 17,907,884 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| ARK ETF Trust | 7,369,790 | 0 | 0 | 0 | For |
| Vanguard | 3,008,638 | 0 | 0 | 0 | For |
| Royce | 2,195,581 | 0 | 0 | 0 | For |
| FIRST EAGLE FUNDS | 1,961,041 | 0 | 0 | 0 | For |
| BlackRock | 1,284,118 | 0 | 0 | 0 | For |
| Dimensional | 470,318 | 0 | 0 | 0 | For |
| BNY Mellon | 312,990 | 0 | 0 | 0 | For |
| Charles Schwab | 201,557 | 0 | 0 | 0 | For |
| American Century | 158,748 | 0 | 0 | 0 | For |
| Russell Investments | 143,683 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 125,339 | 0 | 0 | 0 | For |
| TIAA | 106,509 | 0 | 0 | 0 | For |
| JPMorgan | 97,721 | 0 | 0 | 0 | For |
| Equitable | 81,560 | 0 | 0 | 0 | For |
| Lincoln Financial | 49,927 | 0 | 0 | 0 | For |
| Fidelity | 37,253 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 33,188 | 0 | 0 | 0 | For |
| Global X | 32,469 | 0 | 0 | 0 | For |
| Pacific Life | 30,233 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 29,691 | 0 | 0 | 0 | For |
| Venerable Variable Insurance Trust | 26,500 | 0 | 0 | 0 | For |
| Jackson National | 25,349 | 0 | 0 | 0 | For |
| Virtus | 22,136 | 0 | 0 | 0 | For |
| AQR | 15,781 | 0 | 0 | 0 | For |
| Goldman Sachs | 14,029 | 0 | 0 | 0 | For |
Showing the 25 largest of 46 asset managers. All 46 are in the interactive database (link above).
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 86,526,570 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | ARK ETF Trust | 8.52% |
| 2 | Vanguard | 3.48% |
| 3 | Royce | 2.54% |
| 4 | FIRST EAGLE FUNDS | 2.27% |
| 5 | BlackRock | 1.48% |
| 6 | Dimensional | 0.54% |
| 7 | BNY Mellon | 0.36% |
| 8 | Charles Schwab | 0.23% |
| 9 | American Century | 0.18% |
| 10 | Russell Investments | 0.17% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Third Point | 5.78% |
| 2 | Northern Right Capital Management, L.P. | 3.55% |
| 3 | First Eagle Investment Management, LLC | 2.62% |
| 4 | Amova Asset Management Co., Ltd. | 1.91% |
| 5 | Uniplan Investment Counsel, Inc. | 1.16% |
| 6 | ARK Investment Management LLC | 0.82% |
| 7 | BlackRock | 0.75% |
| 8 | Newton Investment Management North America, LLC | 0.71% |
| 9 | Royce | 0.65% |
| 10 | State Street | 0.61% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.
| Holder | Shares | % outstanding | Source, as of |
|---|---|---|---|
| Steele ExpCo Holdings, LLC | 7,923,000 | 9.16% | Schedule 13G, filed August 20, 2026 |
| BlackRock | 4,568,268 | 5.28% | Form 13F, quarter ended March 31, 2026 |
| Vanguard Group | 3,633,537 | 4.20% | Form 13F, quarter ended March 31, 2026 |
| ARK Investment Management LLC | 2,730,855 | 3.16% | Schedule 13G, filed July 8, 2026 |
| Dimensional Fund Advisors | 1,617,104 | 1.87% | Form 13F, quarter ended March 31, 2026 |
| State Street | 1,346,075 | 1.56% | Form 13F, quarter ended March 31, 2026 |
| BNY Mellon | 1,079,025 | 1.25% | Form 13F, quarter ended March 31, 2026 |
| Morgan Stanley | 766,449 | 0.89% | Form 13F, quarter ended March 31, 2026 |
| Northern Trust | 643,635 | 0.74% | Form 13F, quarter ended March 31, 2026 |
| Renaissance Technologies | 474,886 | 0.55% | Form 13F, quarter ended March 31, 2026 |
Percentages above are of 86,526,570 shares outstanding, as reported by Strata Critical Medical, Inc. on its Form 10-Q dated April 27, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
At Strata Critical Medical, Inc.'s shareholder meeting held May 28, 2026, in the 2025-2026 proxy season, 137 asset managers reported votes on at least one of its 4 ballot items in their SEC Form N-PX filings, covering 625 separate fund positions. On the most widely held item on that ballot — Advisory Vote on the Compensation of our Named Executive Officers. — Strata Critical Medical, Inc.'s filing reports the proposal as approved, with 83% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: Strata Critical Medical, Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 3, 2026.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Strata Critical Medical, Inc.’s 10-Q dated April 27, 2026. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.
Strata Critical Medical, Inc. proxy season coverage: 2024-2025 · 2025-2026 (this page).
Proxy Votes Now, “Strata Critical Medical (SRTA) 2026 Annual Meeting: Vote Results”, https://proxyvotesnow.com/company/strata-critical-medical-inc/2026 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.